Mealey's (April 6, 2016, 10:53 AM EDT) -- CHARLESTON, S.C. — A South Carolina federal judge overseeing the Lipitor/diabetes multidistrict litigation on March 30 excluded the causation opinions of three plaintiff experts and limited the opinion of a fourth expert (In Re: Lipitor [Atorvastatin Calcium] Marketing, Sales Practices and Products Liability Litigation, MDL Docket No. 2502, D. S.C.).
(Opinion available. Document #28-160407-024Z.)
Lipitor is an oral prescription drug prescribed to help lower cholesterol. Plaintiffs allege that it can cause diabetes.
Federal lawsuits were centralized in a multidistrict litigation in the U.S. District Court for...